Delivery Order SPE2DB22D1041-SPE2DB25FTZC3

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,702.72 with a completion date of July 25, 2024. It is a Firm Fixed Price contract for the supply of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,132.30, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of June 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract, valued at $1,993.19, is a Firm Fixed Price Delivery Order with a completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This is a federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product "TYPHIM VI 25 MCG/0.5 ML VIAL 10ML". The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order with a Firm Fixed Price of $7,114.87 and a completion date of April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,119.84 firm fixed-price delivery order is for the pharmaceutical product "TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML", with a completion date of March 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $11,235.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical product, and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $5,291.98 and a completion date of June 10, 2024. The award is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical product. The contract is not a set-aside award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, a delivery order contract valued at $8,426.88, is for the procurement of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a period of performance through March 15, 2024 and is structured as a firm fixed price...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,709.07, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,613.57 firm fixed-price delivery order is for 4567052730 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, and has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB25FTZC3
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $17,364.48 and a completion date of January 16, 2025. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 4/17/25, 8:50 AM